These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 30716792)
41. Identification of key microRNAs associated with diffuse large B-cell lymphoma by analyzing serum microRNA expressions. Meng Y; Quan L; Liu A Gene; 2018 Feb; 642():205-211. PubMed ID: 29128636 [TBL] [Abstract][Full Text] [Related]
43. Down-regulation of microRNA-144-3p and its clinical value in non-small cell lung cancer: a comprehensive analysis based on microarray, miRNA-sequencing, and quantitative real-time PCR data. Chen YJ; Guo YN; Shi K; Huang HM; Huang SP; Xu WQ; Li ZY; Wei KL; Gan TQ; Chen G Respir Res; 2019 Mar; 20(1):48. PubMed ID: 30832674 [TBL] [Abstract][Full Text] [Related]
44. Identification of serum miR-1915-3p and miR-455-3p as biomarkers for breast cancer. Guo J; Liu C; Wang W; Liu Y; He H; Chen C; Xiang R; Luo Y PLoS One; 2018; 13(7):e0200716. PubMed ID: 30048472 [TBL] [Abstract][Full Text] [Related]
45. Decreased expression of MicroRNA-200 family in human breast cancer is associated with lymph node metastasis. Xu F; He H; Huang W; Lin Y; Luo S; Du Q; Duan R Clin Transl Oncol; 2016 Mar; 18(3):283-8. PubMed ID: 26201425 [TBL] [Abstract][Full Text] [Related]
46. Integrated analysis of deregulation microRNA expression in head and neck squamous cell carcinoma. Qi CL; Sheng JF; Huang ML; Zou Y; Wang YP; Wang F; Zeng F; Hua QQ; Chen SM Medicine (Baltimore); 2021 Feb; 100(6):e24618. PubMed ID: 33578572 [TBL] [Abstract][Full Text] [Related]
47. Identification of microRNAs in Nipple Discharge as Potential Diagnostic Biomarkers for Breast Cancer. Zhang K; Zhao S; Wang Q; Yang HS; Zhu J; Ma R Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S536-44. PubMed ID: 25976861 [TBL] [Abstract][Full Text] [Related]
48. Significance of lymphatic invasion combined with size of primary tumor for predicting sentinel lymph node metastasis in patients with breast cancer. Fujii T; Yajima R; Tatsuki H; Suto T; Morita H; Tsutsumi S; Kuwano H Anticancer Res; 2015 Jun; 35(6):3581-4. PubMed ID: 26026130 [TBL] [Abstract][Full Text] [Related]
49. miRNAs derived from circulating small extracellular vesicles as diagnostic biomarkers for nasopharyngeal carcinoma. Jiang L; Zhang Y; Li B; Kang M; Yang Z; Lin C; Hu K; Wei Z; Xu M; Mi J; Wang R; Wu F Cancer Sci; 2021 Jun; 112(6):2393-2404. PubMed ID: 33728743 [TBL] [Abstract][Full Text] [Related]
50. Effects of differential distribution of microvessel density, possibly regulated by miR-374a, on breast cancer prognosis. Li JY; Zhang Y; Zhang WH; Jia S; Kang Y; Tian R Asian Pac J Cancer Prev; 2013; 14(3):1715-20. PubMed ID: 23679262 [TBL] [Abstract][Full Text] [Related]
51. Identification of Dysregulated microRNAs in Glioma Using RNA-sequencing. Liu C; Ge YY; Xie XX; Luo B; Shen N; Liao XS; Bi SQ; Xu T; Xiao SW; Zhang QM Curr Med Sci; 2021 Apr; 41(2):356-367. PubMed ID: 33877554 [TBL] [Abstract][Full Text] [Related]
52. Prediction score model for non-sentinel and four or more nodal metastases using a combined method of one-step nucleic acid amplification and histology in sentinel node-positive breast cancer patients. Jimbo K; Kinoshita T; Ogura T; Watase C; Murata T; Shiino S; Takayama S; Yoshida M Eur J Surg Oncol; 2020 Apr; 46(4 Pt A):516-521. PubMed ID: 31711717 [TBL] [Abstract][Full Text] [Related]
53. Comprehensive analysis of differentially expressed long noncoding RNAs, miRNAs and mRNAs in breast cancer brain metastasis. An M; Zang X; Wang J; Kang J; Tan X; Fu B Epigenomics; 2021 Jul; 13(14):1113-1128. PubMed ID: 34148372 [TBL] [Abstract][Full Text] [Related]
54. Accuracy of CEUS-guided sentinel lymph node biopsy in early-stage breast cancer: a study review and meta-analysis. Cui Q; Dai L; Li J; Xue J World J Surg Oncol; 2020 May; 18(1):112. PubMed ID: 32471428 [TBL] [Abstract][Full Text] [Related]
55. Predictors of non-sentinel lymph node metastasis in clinical early stage (cT1-2N0) breast cancer patients with 1-2 metastatic sentinel lymph nodes. Lale A; Yur M; Özgül H; Alkurt EG; Yıldırım N; Aygen E; Bahadır Öz A; Arıkan TB Asian J Surg; 2020 Apr; 43(4):538-549. PubMed ID: 31519397 [TBL] [Abstract][Full Text] [Related]
56. MicroRNA-30a inhibits cell migration and invasion by downregulating vimentin expression and is a potential prognostic marker in breast cancer. Cheng CW; Wang HW; Chang CW; Chu HW; Chen CY; Yu JC; Chao JI; Liu HF; Ding SL; Shen CY Breast Cancer Res Treat; 2012 Aug; 134(3):1081-93. PubMed ID: 22476851 [TBL] [Abstract][Full Text] [Related]
57. The potential value of miR-1 and miR-374b as biomarkers for colorectal cancer. Wu X; Li S; Xu X; Wu S; Chen R; Jiang Q; Li Y; Xu Y Int J Clin Exp Pathol; 2015; 8(3):2840-51. PubMed ID: 26045793 [TBL] [Abstract][Full Text] [Related]
58. A nine-miRNA signature as a potential diagnostic marker for breast carcinoma: An integrated study of 1,110 cases. Xiong DD; Lv J; Wei KL; Feng ZB; Chen JT; Liu KC; Chen G; Luo DZ Oncol Rep; 2017 Jun; 37(6):3297-3304. PubMed ID: 28440475 [TBL] [Abstract][Full Text] [Related]
59. Predictive Value of Clinicopathological Characteristics for Sentinel Lymph Node Metastasis in Early Breast Cancer. Ding J; Jiang L; Wu W Med Sci Monit; 2017 Aug; 23():4102-4108. PubMed ID: 28839123 [TBL] [Abstract][Full Text] [Related]
60. Identification of microRNAs associated with lymphangiogenesis in human gastric cancer. Yang B; Jing C; Wang J; Guo X; Chen Y; Xu R; Peng L; Liu J; Li L Clin Transl Oncol; 2014 Apr; 16(4):374-9. PubMed ID: 23881463 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]